3 completed, 1 terminated. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Terminated 1 |
Follow Liver Inflammation: new trials by email Literature Review of Liver Inflammation trials Research Report on Liver Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet, Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet - Hepatitis C, Liver Inflammation | Not applicable | Terminated | Kirby Institute | 21 | 2021-02-12 | 2026-05-26 |
| Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. LIVERFASt - Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis | Not applicable | Completed | Fibronostics USA, Inc | 241 | 2021-01-07 | 2022-08-02 |
| Simplified Monitoring Myanmar SM2 Study HCV point of care machine - Hepatitis C, Liver Cirrhoses | Not applicable | Completed | Kirby Institute | 200 | 2019-01-22 | 2021-02-21 |
| Ultrasound Based Acoustic Radiation Force Impulse Imaging Ultrasound-Based Acoustic Radiation Force Impulse (ARFI) - Liver Fibrosis, Liver Inflammation | Not applicable | Completed | University of Michigan | 62 | 2012-11-01 | 2016-10-21 |
Hepatitis (4) · Hepatitis C (2) · Liver Cirrhosis (2) · Fatty Liver (1) · HIV Infections (1) · Non-alcoholic Fatty Liver Disease (1)
Digestive System Diseases (4) · Liver Diseases (4) · Blood-Borne Infections (2) · Communicable Diseases (2) · Fibrosis (2) · Flaviviridae Infections (2) · Hepatitis, Viral, Human (2) · Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · RNA Virus Infections (2) · Virus Diseases (2) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Sofosbuvir (1) · glecaprevir (1) · pibrentasvir (1)
Kirby Institute (2) · Fibronostics USA, Inc (1) · University of Michigan (1)
Australia (2) · United States (2)
Imtiaz Alam, MD (1) · Jonathan Dillman, M.D. (1) · Ronald Quiambao, MD (1) · Sven Henrichwark (1)